These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38159523)

  • 41. A new magnetic resonance imaging tumour response grading scheme for locally advanced rectal cancer.
    Pang X; Xie P; Yu L; Chen H; Zheng J; Meng X; Wan X
    Br J Cancer; 2022 Jul; 127(2):268-277. PubMed ID: 35388140
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Magnetic resonance imaging tumor response score (mrTRS) predicts therapeutic effect and prognosis of locally advanced rectal cancer after neoadjuvant chemoradiotherapy: A prospective, multi-center study.
    Guan Z; Sun RJ; Cao WT; Zhang HM; Yu T; Yu XP; Zhang JX; Zhang XY; Li XT; Zhou ZY; Zhao XM; Wen L; Sun YS
    Radiother Oncol; 2020 Oct; 151():288-295. PubMed ID: 32890612
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Response assessment of locally advanced rectal cancer after neoadjuvant chemoradiotherapy: Is apparent diffusion coefficient useful on 3 T magnetic resonance imaging?
    Boraschi P; Cervelli R; Donati F; Landi E; Cacciato-Insilla A; Campani D; Caramella D
    Colorectal Dis; 2023 May; 25(5):905-915. PubMed ID: 36638020
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China.
    Zhu Y; Sun Y; Hu S; Jiang Y; Yue J; Xue X; Yang L; Xue L
    BMC Gastroenterol; 2017 Mar; 17(1):41. PubMed ID: 28292272
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic value of visual residual tumour cells (VRTC) for patients with esophageal squamous cell carcinomas after neoadjuvant therapy followed by surgery.
    Wang X; Wang H; Wang H; Huang J; Wang X; Jiang Z; Tan L; Jiang D; Hou Y
    BMC Cancer; 2021 Feb; 21(1):111. PubMed ID: 33535987
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The value of GRASP on DCE-MRI for assessing response to neoadjuvant chemotherapy in patients with esophageal cancer.
    Lu Y; Ma L; Qin J; Wang Z; Guo J; Zhao Y; Zhang H; Yan X; Liu H; Li H; Kamel IR; Qu J
    BMC Cancer; 2019 Oct; 19(1):999. PubMed ID: 31651280
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Carcinoembryonic Antigen Improves the Performance of Magnetic Resonance Imaging in the Prediction of Pathologic Response after Neoadjuvant Chemoradiation for Patients with Rectal Cancer.
    Yoo GS; Park HC; Yu JI; Choi DH; Cho WK; Park YS; Park JO; Lim HY; Kang WK; Lee WY; Kim HC; Yun SH; Cho YB; Park YA; Song KD; Kim SH; Ha SY
    Cancer Res Treat; 2020 Apr; 52(2):446-454. PubMed ID: 31588705
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multidetector CT for Restaging Locally Advanced Esophageal Squamous Cell Carcinoma and Assessing Therapeutic Response to Neoadjuvant Chemotherapy.
    Shi Y; Chen Y; Li X; Wang Z; Sun Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Feb; 39(1):133-139. PubMed ID: 28270296
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diffusion-weighted imaging complements T2-weighted MRI for tumour response assessment in squamous anal carcinoma.
    Prezzi D; Muthuswamy K; Amlani A; Owczarczyk K; Elowaidy A; Mistry T; Bassett P; Goh V
    Eur Radiol; 2023 Nov; 33(11):7575-7584. PubMed ID: 37462820
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gene expression profiles of tumor regression grade in locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
    Saigusa S; Tanaka K; Toiyama Y; Matsushita K; Kawamura M; Okugawa Y; Hiro J; Inoue Y; Uchida K; Mohri Y; Kusunoki M
    Oncol Rep; 2012 Sep; 28(3):855-61. PubMed ID: 22711167
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Application value of texture analysis of magnetic resonance images in prediction of neoadjuvant chemoradiotherapy efficacy for rectal cancer].
    Shu Z; Fang S; Ding Z; Mao D; Pang P; Gong X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1051-1058. PubMed ID: 30269327
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fifteen different 18F-FDG PET/CT qualitative and quantitative parameters investigated as pathological response predictors of locally advanced rectal cancer treated by neoadjuvant chemoradiation therapy.
    Maffione AM; Ferretti A; Grassetto G; Bellan E; Capirci C; Chondrogiannis S; Gava M; Marzola MC; Rampin L; Bondesan C; Colletti PM; Rubello D
    Eur J Nucl Med Mol Imaging; 2013 Jun; 40(6):853-64. PubMed ID: 23417501
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The value of 18F-FDG PET/CT for assessing the response to neoadjuvant therapy in locally advanced rectal cancer.
    Murcia Duréndez MJ; Frutos Esteban L; Luján J; Frutos MD; Valero G; Navarro Fernández JL; Mohamed Salem L; Ruiz Merino G; Claver Valderas MA
    Eur J Nucl Med Mol Imaging; 2013 Jan; 40(1):91-7. PubMed ID: 23081822
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
    Ryan R; Gibbons D; Hyland JM; Treanor D; White A; Mulcahy HE; O'Donoghue DP; Moriarty M; Fennelly D; Sheahan K
    Histopathology; 2005 Aug; 47(2):141-6. PubMed ID: 16045774
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Comprehensive Prediction Model Based on MRI Radiomics and Clinical Factors to Predict Tumor Response After Neoadjuvant Chemoradiotherapy in Rectal Cancer.
    Jiang H; Guo W; Yu Z; Lin X; Zhang M; Jiang H; Zhang H; Sun Z; Li J; Yu Y; Zhao S; Hu H
    Acad Radiol; 2023 Sep; 30 Suppl 1():S185-S198. PubMed ID: 37394412
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Classification of pathologic response to neoadjuvant therapy in esophageal and junctional cancer: assessment of existing measures and proposal of a novel 3-point standard.
    Donohoe CL; O'Farrell NJ; Grant T; King S; Clarke L; Muldoon C; Reynolds JV
    Ann Surg; 2013 Nov; 258(5):784-92; discussion 792. PubMed ID: 24045450
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Usefulness of Restaging Pelvis Magnetic Resonance Imaging After Neoadjuvant Concurrent Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer.
    Fahmawi Y; Smith C; Grimm L; Khullar S; Rider P; Hunter J; Iliff G; Mneimneh W; Roveda K; Wang B; Prodduturvar P; Alkharabsheh O; McCormick B; Mizrahi M; Khushman M
    Clin Colorectal Cancer; 2020 Dec; 19(4):e281-e287. PubMed ID: 32694005
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MRI tumor volume reduction rate vs tumor regression grade in the pre-operative re-staging of locally advanced rectal cancer after chemo-radiotherapy.
    Neri E; Guidi E; Pancrazi F; Castagna M; Castelluccio E; Balestri R; Buccianti P; Masi L; Falcone A; Manfredi B; Faggioni L; Bartolozzi C
    Eur J Radiol; 2015 Dec; 84(12):2438-43. PubMed ID: 26462793
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation and Comparison of Predictive Value of Tumor Regression Grades according to Mandard and Becker in Locally Advanced Gastric Adenocarcinoma.
    Tong Y; Zhu Y; Zhao Y; Shan Z; Liu D; Zhang J
    Cancer Res Treat; 2021 Jan; 53(1):112-122. PubMed ID: 32777876
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predicting locally advanced rectal cancer response to neoadjuvant therapy with
    Giannini V; Mazzetti S; Bertotto I; Chiarenza C; Cauda S; Delmastro E; Bracco C; Di Dia A; Leone F; Medico E; Pisacane A; Ribero D; Stasi M; Regge D
    Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):878-888. PubMed ID: 30637502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.